Atrium Therapeutics (RNA) Q4 2022 Earnings

Feb 28Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.93
-0.86
-0.78
-0.71

Details

Expected EPS
-0.89
Actual EPS
-0.88
Surprise EPS
0.01
Surprise Percent
+1.12%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-0.88⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts